Evidence map›Paper›PMID 42206851›Full record

ArticleSexually transmitted diseases2026

Correlates of Sexually Transmitted Infection Positivity and Implementation of Point-of-Care Sexually Transmitted Infection Testing at a Mobile Clinic for Women Who Inject Drugs in Seattle, WA.

Abigail G Fessler, Maria A Corcorran, Lauren R Violette, Kenneth A Tapia, Thomas S Fitzpatrick, Stacey Jones, Elizabeth J Austin, Sara N Glick, Emily C Williams, Shireesha Dhanireddy and 1 more

Abstract read
In one paragraph

Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Abigail G FesslerFrom the Department of Medicine, University of Washington, Seattle, WA.
Maria A CorcorranFrom the Department of Medicine, University of Washington, Seattle, WA.
Lauren R VioletteFrom the Department of Medicine, University of Washington, Seattle, WA.
Kenneth A TapiaDepartment of Global Health, University of Washington, Seattle, WA.
Thomas S FitzpatrickFrom the Department of Medicine, University of Washington, Seattle, WA.
Stacey JonesHarborview Medical Center, Seattle, WA.
Elizabeth J AustinDepartment of Health Systems and Population Health, University of Washington, Seattle, WA.
Sara N GlickFrom the Department of Medicine, University of Washington, Seattle, WA.
Emily C WilliamsDepartment of Health Systems and Population Health, University of Washington, Seattle, WA.
Shireesha DhanireddyFrom the Department of Medicine, University of Washington, Seattle, WA.
Jenell StewartDivision of Infectious Diseases, Hennepin Healthcare, Minneapolis, MN.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
Alcohol Research Consortium in HIV: Relapse Prevention ArmP01AA029544 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI · 2021 to 2025
$7.1M
Combination primary care and prevention services for women who inject drugs and exchange sex in Seattle, WashingtonR34DA054588 · NIDA · UNIVERSITY OF WASHINGTON · PI CORCORRAN, MARIA ANN, STEWART, JENELL · 2022 to 2024
$700k
Centering HIV Stigma in Clinical Conversations to increase Alcohol Treatment Uptake (CHAT)K01AA032461 · NIAAA · UNIVERSITY OF WASHINGTON · PI Elizabeth Joy Austin · 2025 to 2026
$360k
NIAAA NIH HHS K01 AA032461NIAAA NIH HHS P01 AA029544NIAID NIH HHS P30 AI027757NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI007433NIDA NIH HHS R34 DA054588
6 · The paper itself

Abstract

backgroundWomen who inject drugs (WWID) face complex barriers to engagement in sexual healthcare. We used point-of-care (POC) testing to assess sexually transmitted infection (STI) prevalence, correlates, and treatment delivery, as well as testing acceptability and feasibility, at a mobile clinic for WWID in Seattle, Washington.

methodsWe implemented a mobile clinic offering substance use and sexual health services for women ≥18 years with a history of injecting drugs and negative or unknown HIV status. We offered POC testing for trichomonas, syphilis, chlamydia, gonorrhea, and HIV at enrollment, 3 months, and 6 months. Participant surveys assessed demographics, behaviors, and acceptability of POC testing. Provider surveys assessed the feasibility of care delivery. We used bivariate analysis to identify correlates of STI positivity.

resultsAmong 50 WWID enrolled, 73% were unstably housed, and 56% reported a previous STI. In the preceding 3 months, 34% reported transactional sex, and 38% had ≥2 sexual partners. During the study period, 26% of women tested positive for trichomonas, 4% for syphilis, 3% each for chlamydia and gonorrhea, and 0% for HIV. Same-day treatment was provided in 94% of cases. STI positivity was associated with ≥2 sexual partners (odds ratio: 5.8, P = 0.02) and transactional sex (odds ratio: 4.8, P = 0.02). POC testing was acceptable, and 84% preferred it over traditional methods. Staff encountered challenges with POC logistics and competing participant priorities.

conclusionsSTI prevalence, particularly trichomonas, was high among WWID, but low-barrier POC STI testing services were acceptable and feasible, leading to same-day STI treatment in most cases.

Indexed as

Mobile Health UnitsPoint-of-Care SystemsPoint-of-Care TestingSexually Transmitted DiseasesSubstance Abuse, IntravenousAdolescentAdultChlamydia InfectionsFemaleGonorrheaHIV InfectionsHumansMiddle AgedPatient Acceptance of Health CarePrevalenceRapid Diagnostic Tests

Identifiers

PMID42206851
PMCPMC13271362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.